-
1
-
-
84878626743
-
Ezetimibe therapy for dyslipidemia: An update
-
Katsiki N, Theocharidou E, Karagiannis A, Athyros VG, Mikhailidis DP. Ezetimibe therapy for dyslipidemia: an update. Curr Pharm Des. 2013;19:3107-3114.
-
(2013)
Curr Pharm des
, vol.19
, pp. 3107-3114
-
-
Katsiki, N.1
Theocharidou, E.2
Karagiannis, A.3
Athyros, V.G.4
Mikhailidis, D.P.5
-
2
-
-
84860833364
-
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): A randomised, open-label, phase 3 non-inferiority trial
-
Engert A, Haverkamp H, Kobe C, Markova J, Renner C, Ho A, et al. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet. 2012;379:1791-1799.
-
(2012)
Lancet
, vol.379
, pp. 1791-1799
-
-
Engert, A.1
Haverkamp, H.2
Kobe, C.3
Markova, J.4
Renner, C.5
Ho, A.6
-
3
-
-
0035572836
-
Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in apoE knockout mice
-
Davis HR Jr, Compton DS, Hoos L, Tetzloff G. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice. Arterioscler Thromb Vasc Biol. 2001;21:2032-2038. (Pubitemid 34219758)
-
(2001)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.21
, Issue.12
, pp. 2032-2038
-
-
Davis Jr., H.R.1
Compton, D.S.2
Hoos, L.3
Tetzloff, G.4
-
4
-
-
77949917890
-
Pleiotropic effects of ezetimibe: Do they really exist?
-
Kalogirou M, Tsimihodimos V, Elisaf M. Pleiotropic effects of ezetimibe: do they really exist? Eur J Pharmacol. 2010;633:62-70.
-
(2010)
Eur J Pharmacol
, vol.633
, pp. 62-70
-
-
Kalogirou, M.1
Tsimihodimos, V.2
Elisaf, M.3
-
5
-
-
0035831089
-
The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys
-
DOI 10.1016/S0014-2999(01)00825-1, PII S0014299901008251
-
van Heek M, Compton DS, Davis HR. The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. Eur J Pharmacol. 2001;415:79-84. (Pubitemid 32197622)
-
(2001)
European Journal of Pharmacology
, vol.415
, Issue.1
, pp. 79-84
-
-
Van Heek, M.1
Compton, D.S.2
Davis, H.R.3
-
6
-
-
77951676608
-
Control of cell proliferation in atherosclerosis: Insights from animal models and human studies
-
Fuster JJ, Fernandez P, Gonzalez-Navarro H, Silvestre C, Nabah YN, Andres V. Control of cell proliferation in atherosclerosis: insights from animal models and human studies. Cardiovasc Res. 2010;86:254-264.
-
(2010)
Cardiovasc Res
, vol.86
, pp. 254-264
-
-
Fuster, J.J.1
Fernandez, P.2
Gonzalez-Navarro, H.3
Silvestre, C.4
Nabah, Y.N.5
Andres, V.6
-
7
-
-
84866562484
-
Antitumor activity of novel chimeric peptides derived from cyclinD/CDK4 and the protein transduction domain 4
-
Wang H, Chen X, Chen Y, Sun L, Li G, Zhai M, et al. Antitumor activity of novel chimeric peptides derived from cyclinD/CDK4 and the protein transduction domain 4. Amino Acids. 2013;44:499-510.
-
(2013)
Amino Acids
, vol.44
, pp. 499-510
-
-
Wang, H.1
Chen, X.2
Chen, Y.3
Sun, L.4
Li, G.5
Zhai, M.6
-
8
-
-
0032835829
-
Macrophages - Proliferation, activation, and cell cycle proteins
-
Vadiveloo PK. Macrophages - proliferation, activation, and cell cycle proteins. J Leukoc Biol. 1999;66:579-582. (Pubitemid 29489883)
-
(1999)
Journal of Leukocyte Biology
, vol.66
, Issue.4
, pp. 579-582
-
-
Vadiveloo, P.K.1
-
9
-
-
77951216669
-
Cholesterol inhibits M-type K+ channels via protein kinase C-dependent phosphorylation in sympathetic neurons
-
Lee SY, Choi HK, Kim ST, Chung S, Park MK, Cho JH, et al. Cholesterol inhibits M-type K+ channels via protein kinase C-dependent phosphorylation in sympathetic neurons. J Biol Chem. 2010;285:10939-10950.
-
(2010)
J Biol Chem
, vol.285
, pp. 10939-10950
-
-
Lee, S.Y.1
Choi, H.K.2
Kim, S.T.3
Chung, S.4
Park, M.K.5
Cho, J.H.6
-
10
-
-
58149496083
-
Effects and underlying mechanisms of curcumin on the proliferation of vascular smooth muscle cells induced by Chol:MbetaCD
-
Qin L, Yang YB, Tuo QH, Zhu BY, Chen LX, Zhang L, et al. Effects and underlying mechanisms of curcumin on the proliferation of vascular smooth muscle cells induced by Chol:MbetaCD. Biochem Biophys Res Commun. 2009;379:277-282.
-
(2009)
Biochem Biophys Res Commun
, vol.379
, pp. 277-282
-
-
Qin, L.1
Yang, Y.B.2
Tuo, Q.H.3
Zhu, B.Y.4
Chen, L.X.5
Zhang, L.6
-
11
-
-
13444254354
-
Onychin inhibits proliferation of vascular smooth muscle cells by regulating cell cycle
-
DOI 10.1111/j.1745-7254.2005.00526.x
-
Yang M, Huang HL, Zhu BY, Tuo QH, Liao DF. Onychin inhibits proliferation of vascular smooth muscle cells by regulating cell cycle. Acta Pharmacol Sin. 2005;26:205-211. (Pubitemid 40203967)
-
(2005)
Acta Pharmacologica Sinica
, vol.26
, Issue.2
, pp. 205-211
-
-
Yang, M.1
Huang, H.-L.2
Zhu, B.-Y.3
Tuo, Q.-H.4
Liao, D.-F.5
-
12
-
-
0032588170
-
1-to-S-phase transition
-
Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol. 1999;19:2690-2698. (Pubitemid 29144513)
-
(1999)
Molecular and Cellular Biology
, vol.19
, Issue.4
, pp. 2690-2698
-
-
Hinz, M.1
Krappmann, D.2
Eichten, A.3
Heder, A.4
Scheidereit, C.5
Strauss, M.6
-
13
-
-
55949097007
-
Effects of rosiglitazone on the proliferation of vascular smooth muscle cell induced by high glucose
-
Ling HY, Hu B, Wang BX, Zu XY, Feng SD, Ou HS, et al. Effects of rosiglitazone on the proliferation of vascular smooth muscle cell induced by high glucose. Cardiovasc Drugs Ther. 2008;22:453-460.
-
(2008)
Cardiovasc Drugs Ther
, vol.22
, pp. 453-460
-
-
Ling, H.Y.1
Hu, B.2
Wang, B.X.3
Zu, X.Y.4
Feng, S.D.5
Ou, H.S.6
-
14
-
-
34547841542
-
Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway
-
DOI 10.1016/j.ejphar.2007.05.050, PII S0014299907006115
-
Yang YB, Yang YX, Su B, Tang YL, Zhu BY, Hu ZW, et al. Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway. Eur J Pharmacol. 2007;570:125-134. (Pubitemid 47247670)
-
(2007)
European Journal of Pharmacology
, vol.570
, Issue.1-3
, pp. 125-134
-
-
Yang, Y.-B.1
Yang, Y.-X.2
Su, B.3
Tang, Y.-L.4
Zhu, B.-Y.5
Hu, Z.-W.6
Li, G.-Y.7
Li, Y.-J.8
Liao, D.-F.9
-
15
-
-
43549102626
-
Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells
-
Qin L, Zhang X, Zhang L, Feng Y, Weng GX, Li MZ, et al. Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 2008;371:531-535.
-
(2008)
Biochem Biophys Res Commun
, vol.371
, pp. 531-535
-
-
Qin, L.1
Zhang, X.2
Zhang, L.3
Feng, Y.4
Weng, G.X.5
Li, M.Z.6
-
16
-
-
58149504938
-
Effect of pravastatin on cholesteryl esters in foam cells and the relation with caveolin-1
-
(text in Chinese)
-
Qin L, Qin XP, Wang Z, Zhu BY, Liao DF. [Effect of pravastatin on cholesteryl esters in foam cells and the relation with caveolin-1]. Sheng Li Xue Bao. 2006;58:47-52. (text in Chinese)
-
(2006)
Sheng Li Xue Bao
, vol.58
, pp. 47-52
-
-
Qin, L.1
Qin, X.P.2
Wang, Z.3
Zhu, B.Y.4
Liao, D.F.5
-
17
-
-
0034127782
-
Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity
-
Dubey RK, Jackson EK, Gillespie DG, Zacharia LC, Imthurn B, Keller PJ. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler Thromb Vasc Biol. 2000;20:964-972. (Pubitemid 30207569)
-
(2000)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.20
, Issue.4
, pp. 964-972
-
-
Dubey, R.K.1
Jackson, E.K.2
Gillespie, D.G.3
Zacharia, L.C.4
Imthurn, B.5
Keller, P.J.6
-
19
-
-
84864277224
-
Alpha-lipoic acid attenuates atherosclerotic lesions and inhibits proliferation of vascular smooth muscle cells through targeting of the Ras/MEK/ERK signaling pathway
-
Lee WR, Kim A, Kim KS, Park YY, Park JH, Kim KH, et al. Alpha-lipoic acid attenuates atherosclerotic lesions and inhibits proliferation of vascular smooth muscle cells through targeting of the Ras/MEK/ERK signaling pathway. Mol Biol Rep. 2012;39:6857-6866.
-
(2012)
Mol Biol Rep
, vol.39
, pp. 6857-6866
-
-
Lee, W.R.1
Kim, A.2
Kim, K.S.3
Park, Y.Y.4
Park, J.H.5
Kim, K.H.6
-
20
-
-
84870749692
-
Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: Therapeutic effects of ezetimibe
-
Sato K, Nakano K, Katsuki S, Matoba T, Osada K, Sawamura T, et al. Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe. J Atheroscler Thromb. 2012;19:986-998.
-
(2012)
J Atheroscler Thromb
, vol.19
, pp. 986-998
-
-
Sato, K.1
Nakano, K.2
Katsuki, S.3
Matoba, T.4
Osada, K.5
Sawamura, T.6
-
21
-
-
84876288577
-
Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice
-
Xie P, Jia L, Ma Y, Ou J, Miao H, Wang N, et al. Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice. Arterioscler Thromb Vasc Biol. 2013;33:920-925.
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, pp. 920-925
-
-
Xie, P.1
Jia, L.2
Ma, Y.3
Ou, J.4
Miao, H.5
Wang, N.6
-
22
-
-
10744221008
-
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
-
DOI 10.1126/science.1093131
-
Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004;303:1201-1204. (Pubitemid 38233587)
-
(2004)
Science
, vol.303
, Issue.5661
, pp. 1201-1204
-
-
Altmann, S.W.1
Davis Jr., H.R.2
Zhu, L.-J.3
Yao, X.4
Hoos, L.M.5
Tetzloff, G.6
Iyer, S.P.N.7
Maguire, M.8
Golovko, A.9
Zeng, M.10
Wang, L.11
Murgolo, N.12
Graziano, M.P.13
-
23
-
-
60649083150
-
Vascular protective effects of ezetimibe in ApoE-deficient mice
-
Nakagami H, Osako MK, Takami Y, Hanayama R, Koriyama H, Mori M, et al. Vascular protective effects of ezetimibe in ApoE-deficient mice. Atherosclerosis. 2009;203:51-58.
-
(2009)
Atherosclerosis
, vol.203
, pp. 51-58
-
-
Nakagami, H.1
Osako, M.K.2
Takami, Y.3
Hanayama, R.4
Koriyama, H.5
Mori, M.6
-
24
-
-
36549013633
-
Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome
-
DOI 10.1016/j.febslet.2007.11.023, PII S0014579307011672
-
Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, Okazaki M, et al. Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett. 2007;581:5664-5670. (Pubitemid 350179776)
-
(2007)
FEBS Letters
, vol.581
, Issue.29
, pp. 5664-5670
-
-
Deushi, M.1
Nomura, M.2
Kawakami, A.3
Haraguchi, M.4
Ito, M.5
Okazaki, M.6
Ishii, H.7
Yoshida, M.8
-
25
-
-
33746930302
-
Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease
-
Assy N, Grozovski M, Bersudsky I, Szvalb S, Hussein O. Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease. World J Gastroenterol. 2006;12:4369-4376. (Pubitemid 44194531)
-
(2006)
World Journal of Gastroenterology
, vol.12
, Issue.27
, pp. 4369-4376
-
-
Assy, N.1
Grozovski, M.2
Bersudsky, I.3
Szvalb, S.4
Hussein, O.5
-
26
-
-
68749102069
-
Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect
-
Gomez-Garre D, Munoz-Pacheco P, Gonzalez-Rubio ML, Aragoncillo P, Granados R, Fernandez-Cruz A. Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect. Br J Pharmacol. 2009;156:1218-1227.
-
(2009)
Br J Pharmacol
, vol.156
, pp. 1218-1227
-
-
Gomez-Garre, D.1
Munoz-Pacheco, P.2
Gonzalez-Rubio, M.L.3
Aragoncillo, P.4
Granados, R.5
Fernandez-Cruz, A.6
-
27
-
-
33751187647
-
Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis
-
Kappert K, Sparwel J, Sandin A, Seiler A, Siebolts U, Leppanen O, et al. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler Thromb Vasc Biol. 2006;26:2644-2651.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 2644-2651
-
-
Kappert, K.1
Sparwel, J.2
Sandin, A.3
Seiler, A.4
Siebolts, U.5
Leppanen, O.6
-
29
-
-
9444236895
-
Minireview: Cyclin D1: Normal and abnormal functions
-
DOI 10.1210/en.2004-0959
-
Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology. 2004;145:5439-5447. (Pubitemid 39564581)
-
(2004)
Endocrinology
, vol.145
, Issue.12
, pp. 5439-5447
-
-
Fu, M.1
Wang, C.2
Li, Z.3
Sakamaki, T.4
Pestell, R.G.5
-
30
-
-
0029033861
-
The retinoblastoma protein and cell cycle control
-
Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330.
-
(1995)
Cell
, vol.81
, pp. 323-330
-
-
Weinberg, R.A.1
-
31
-
-
0035896625
-
Interaction between YY1 and the retinoblastoma protein. Regulation of cell cycle progression in differentiated cells
-
Petkova V, Romanowski MJ, Sulijoadikusumo I, Rohne D, Kang P, Shenk T, et al. Interaction between YY1 and the retinoblastoma protein. Regulation of cell cycle progression in differentiated cells. J Biol Chem. 2001;276:7932-7936.
-
(2001)
J Biol Chem
, vol.276
, pp. 7932-7936
-
-
Petkova, V.1
Romanowski, M.J.2
Sulijoadikusumo, I.3
Rohne, D.4
Kang, P.5
Shenk, T.6
-
32
-
-
0037853130
-
YY1 is regulated by O-linked N-acetylglucosaminylation (O-GlcNAcylation)
-
DOI 10.1074/jbc.M300789200
-
Hiromura M, Choi CH, Sabourin NA, Jones H, Bachvarov D, Usheva A. YY1 is regulated by O-linked N-acetylglucosaminylation (O-glcNAcylation). J Biol Chem. 2003;278:14046-14052. (Pubitemid 36799949)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.16
, pp. 14046-14052
-
-
Hiromura, M.1
Choi, C.H.2
Sabourin, N.A.3
Jones, H.4
Bachvarov, D.5
Usheva, A.6
-
33
-
-
78249237183
-
Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway
-
Yoo AR, Koh SH, Cho GW, Kim SH. Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway. J Atheroscler Thromb. 2010;17:1009-1018.
-
(2010)
J Atheroscler Thromb
, vol.17
, pp. 1009-1018
-
-
Yoo, A.R.1
Koh, S.H.2
Cho, G.W.3
Kim, S.H.4
-
34
-
-
74449083970
-
Static pressure drives proliferation of vascular smooth muscle cells via caveolin-1/ERK1/2 pathway
-
Luo DX, Cheng J, Xiong Y, Li J, Xia C, Xu C, et al. Static pressure drives proliferation of vascular smooth muscle cells via caveolin-1/ERK1/2 pathway. Biochem Biophys Res Commun. 2010;391:1693-1697.
-
(2010)
Biochem Biophys Res Commun
, vol.391
, pp. 1693-1697
-
-
Luo, D.X.1
Cheng, J.2
Xiong, Y.3
Li, J.4
Xia, C.5
Xu, C.6
-
35
-
-
0037378403
-
Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney
-
DOI 10.1046/j.1523-1755.2003.00874.x
-
Masaki T, Foti R, Hill PA, Ikezumi Y, Atkins RC, Nikolic-Paterson DJ. Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int. 2003;63:1256-1264. (Pubitemid 36349991)
-
(2003)
Kidney International
, vol.63
, Issue.4
, pp. 1256-1264
-
-
Masaki, T.1
Foti, R.2
Hill, P.A.3
Ikezumi, Y.4
Atkins, R.C.5
Nikolic-Paterson, D.J.6
-
36
-
-
0029786329
-
Cyclin D1 expression is regulated positively by the p42/p44(MAPK) and negatively by the p38/HOG(MAPK) pathway
-
DOI 10.1074/jbc.271.34.20608
-
Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem. 1996;271:20608-20616. (Pubitemid 26281839)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.34
, pp. 20608-20616
-
-
Lavoie, J.N.1
L'Allemain, G.2
Brunei, A.3
Muller, R.4
Pouyssegur, J.5
-
37
-
-
0030883584
-
1 phase
-
Weber JD, Raben DM, Phillips PJ, Baldassare JJ. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J. 1997;326 Pt 1:61-68. (Pubitemid 27386918)
-
(1997)
Biochemical Journal
, vol.326
, Issue.1
, pp. 61-68
-
-
Weber, J.D.1
Raben, D.M.2
Phillips, P.J.3
Baldassare, J.J.4
-
38
-
-
68149132138
-
Specific phosphorylation and activation of ERK1c by MEK1b: A unique route in the ERK cascade
-
Shaul YD, Gibor G, Plotnikov A, Seger R. Specific phosphorylation and activation of ERK1c by MEK1b: a unique route in the ERK cascade. Genes Dev. 2009;23:1779-1790.
-
(2009)
Genes Dev
, vol.23
, pp. 1779-1790
-
-
Shaul, Y.D.1
Gibor, G.2
Plotnikov, A.3
Seger, R.4
-
39
-
-
79960039308
-
The ERK cascade: Distinct functions within various subcellular organelles
-
Wortzel I, Seger R. The ERK cascade: distinct functions within various subcellular organelles. Genes Cancer. 2011;2:195-209.
-
(2011)
Genes Cancer
, vol.2
, pp. 195-209
-
-
Wortzel, I.1
Seger, R.2
|